Short-Term Morphofunctional Changes in Previously Treated Neovascular AMD Eyes Switched to Brolucizumab.

J Clin Med · 2022 · PMC9570643 · PMID 36233385

Europe PMC DOI

hedged sentence

0.1600

closest p · 3.2× alpha

0.1600

boldest claim

The sentences

did not reach statistical significancep = 0.16not close (p > 0.1)

In detail, CMT at T2 was thicker in comparison with T1 values, although this difference did not reach statistical significance (290.4 ± 65.6 μm and 269.1 ± 46.8 μm, p = 0.16).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.